S100A12 and atrial fibrillation: By using an acute sepsis mouse model, we further established S100A12 as a key gene for new-onset AF in sepsis and examined amlexanox's impact on the S100A12 gene in treating this condition, underscoring S100A12's role in augmenting AF risk through inflammation promotion.